Evidence map›Paper›PMID 37823649›Full record

ArticleJournal of clinical microbiology2023

Hepatitis E virus neutralization by porcine serum antibodies.

Nele Gremmel, Oliver Keuling, Martin Eiden, Martin H Groschup, Reimar Johne, Paul Becher, Christine Baechlein

Open access · hybridAbstract read
In one paragraph

Article in Journal of clinical microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Nele GremmelDepartment of Infectious Diseases, Institute of Virology, University of Veterinary Medicine , Hannover, Germany.ORCID 0000-0002-1853-4049
Oliver KeulingInstitute for Terrestrial and Aquatic Wildlife Research, University of Veterinary Medicine , Hannover, Germany.
Martin EidenInstitute of Novel and Emerging Infectious Diseases, Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health , Greifswald, Insel Riems, Germany.
Martin H GroschupInstitute of Novel and Emerging Infectious Diseases, Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health , Greifswald, Insel Riems, Germany.ORCID 0000-0003-0215-185X
Reimar JohneDepartment of Biological Safety, German Federal Institute for Risk Assessment , Berlin, Germany.
Paul BecherDepartment of Infectious Diseases, Institute of Virology, University of Veterinary Medicine , Hannover, Germany.ORCID 0000-0001-7857-1354
Christine BaechleinDepartment of Infectious Diseases, Institute of Virology, University of Veterinary Medicine , Hannover, Germany.ORCID 0000-0002-2586-2366
University of Veterinary Medicine Hannover, Foundation · DEFriedrich-Loeffler-Institut · DEFederal Institute for Risk Assessment · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The consumption of raw or undercooked meat products poses a serious risk for human hepatitis E virus (HEV) infections. In many high-income countries, domestic pigs and wild boars represent the main animal reservoirs for HEV and are usually identified by reverse transcription-PCR and antibody enzyme-linked immunosorbent assay (ELISA). In order to characterize the humoral immune response in more detail, a cell culture-based serum neutralization assay using a culture-adapted HEV strain was established here. Measurement of neutralizing antibodies was only possible after removing the viral quasi-envelope by detergent treatment. Serum samples of 343 wild boars from Northern Germany were first analyzed for anti-HEV IgG using an in-house ELISA, resulting in 19% positive samples. Subsequently, a subset of 41 representative samples was tested with the neutralization assay, and the results correlated well with those obtained by ELISA. Not only the human HEV strain 47832c but also two porcine HEV strains were shown to be neutralized by porcine serum antibodies. Neutralizing activity was also found in samples containing both HEV-specific antibodies and HEV RNA. Testing of serum samples derived from two experimentally infected domestic pigs showed a steep increase in neutralizing activity at 24 or 51 days post infection, dependent on the used infectious dose. The developed assay can be useful for characterization of the humoral immune response after HEV infection and for assessing the efficiency of HEV vaccine candidates.

Indexed as

Hepatitis EHepatitis E virusSwine DiseasesAnimalsEnzyme-Linked Immunosorbent AssayHepatitis AntibodiesHumansRNA, ViralSus scrofaSwineHepatitis AntibodiesRNA, Viralassay developmenthepatitis E virusimmune responseneutralizing antibodies

Identifiers

PMID37823649
PMCPMC10662371
OpenAlexW4387563634

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.